Acute Care Flashcards

1
Q

Absorption

Oral absorption is ___ / ___ in critically ill patients
- alterations in gastric emptying, gastric motility
- interactions with enteral feeding / GI tubes
- GI injury/disease

A

impaired/unpredictable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Distribution

Alterations vary between different critically ill patient populations
- relates in part to ___ status
- hydrophilic drugs (e.g., aminoglycosides) have ___ Vd in critically ill
surgical/trauma patients (~ __ - __ L/kg) than in medical patients (~ ___ L/kg)

A
  • fluid
  • higher
  • 0.3-0.35, 0.25
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Distribution

Alterations in plasma protein binding
* ___ albumin
* ___protein binding of many drugs
* ___ acute phase proteins (e.g., α1-acid glycoprotein)
* ___ protein binding of drugs that bind α1-acid glycoprotein

A
  • decreased
  • decreased
  • increased
  • increased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Metabolism

Hepatic metabolism
* hepatic blood flow
* enzyme expression and activity
* protein binding

In general: hepatic enzyme expression and activity may be ___ in some critically ill patients
* limited data

A

decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Renal Elimination

Renal dysfunction is a common complication during critical illness
* shock, sepsis-related organ failure
* nephrotoxic drugs
* HD or continuous renal replacement therapy (e.g., CVVH, etc) is common in
ICU
* Some disease states may be associated with ___ renal elimination
* burns
* trauma

A

increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sepsis

life threatening ___ dysfunction caused by dysregulated response to
infection
* immune ___
* coagulation and thrombosis leading to endothelial injury
* high mortality rates (~30%)
* can occur in response to any ___ (bacterial most common) and any site of infection (common: lungs, bloodstream, urinary tract)
* no specific drug therapy, early detection and supportive therapy is critical
* antibiotic therapy (broad spectrum IV antibiotics) and source control

A
  • organ
  • dysregulated
  • pathogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Septic shock

sepsis associated with ___ collapse
- ___ related to decreased vascular tone

treatment
* ___ (crystalloids, colloids)
* ___ (increase vascular tone, potentially cardiac output)
* target MAP ≥ 65 mm Hg
* ___ preferred, also phenylephrine, epinephrine, dopamine
* ___ (add-on)
* ___ (inotrope, not a vasopressor)
* corticosteroids (IV ___ ) if refractory

A
  • CV
  • hypotension
  • fluids
  • vasopressors
  • norepinephrine
  • vasopressin
  • dobutamine
  • hydrocortisone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Respiratory Failure

  • respiratory failure/mechanical ___ is a common reason for ICU admission
  • causes: airway compromise, hypoventilation, hypoxic failure (poor air exchange), inability to
    protect airway, etc

Acute Respiratory Distress Syndrome (ARDS)
* life threatening respiratory failure characterized by acute, diffuse ___ lung injury
* 25-40% mortality
* risks include pneumonia, sepsis, trauma, aspiration, others
* often requires mechanical ventilation with ___ , potentially ___ blockade
* ___ may decrease mortality in severe ARDS

A
  • ventilation
  • inflammatory
  • sedation, neuromuscular
  • corticosteroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

General Supportive Care

“FAST HUGS BID”

A

F: feeding/fluids
A: analgesia
S: sedation
T: thromboprophylaxis

H: HOB elevation
U: Ulcer (stress ulcer) prophylaxis
G: glycemic control
S: spontateous awakening trial, spontaneeous breathing trial

B: bowel regimen
I: indewelling catherters
D: de-escalation of antibiotics/delirium assessment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

General Supportive Care

Feeding
* many ICU patients unable to take adequate oral intake

may have specialized nutritional requirements
* liver, renal failure
* ___ caloric, nutrient needs (trauma, surgery, burn)

enteral nutrition (“tube feeds”) and parenteral nutrition (“TPN”) common
* ___ preferred (”if the gut works, use it”)
* can be complicated by decreased GI motility, underlying disease states

A

increased
enteral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

General Supportive Care

Fluids
* goal is adequate ___ and meeting ___ requirements without causing fluid overload
* carefully monitor “IN’s” and “OUT’s”

A
  • resuscitation
  • maintenance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

General Supportive Care

Thromboprophylaxis

most critically patients have risk factors for venous thromboembolism (VTE)
- ___
- trauma, surgery, use of vascular catheters, sepsis, hypercoagulable states
- cancer, obesity, prior history of VTE

can be complicated by underlying bleeding risks, active bleeding, need for
invasive procedures, neuraxial anesthesia

the majority of ICU patients should receive pharmacological VTE ___ unless sufficiently mobile and very low risk OR contraindications to pharmacological prophylaxis

A
  • immobility
  • prophylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

General Supportive Care

Thromboprophylaxis
* ___ generally preferred over UFH
* others: fondaparinux, bivalrudin, argatroban, warfarin, dabigatran, rivaroxaban, apixaban

___ prophylaxis in patients with contraindications to pharmacologic prophylaxix

A

LMWH
mechanical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

General Supportive Care - Thromboprophylaxis

UFH dosing and monitoring
* ___ U SC q __ h or q12h (possibly 7500 U SC q12h)
* monitoring: s/s of ___, CBC (platelets for ___ )
* no adjustment for ___ dysfunction

enoxaparin
* __ mg SC q12h, __ mg SC q __ h (may dose base on anti-Xa activity in selected patients)
* monitoring: s/s of ___ , CBC (platelets for ___ )
* CrCl < ___ ml/min: __ mg SC q __ h

dalteparin
* ___ USC q24h
* monitoring: s/s of bleeding, CBC (platelets for HIT)
* CrCl < 30 ml/min: no adjustment necessary

A
  • 5000, 8
  • bleeding, HIT
  • renal
  • 30, 40, 24
  • bleeding, HIT
  • 30, 30, 24
  • 5000
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

General Supportive Care

Head of Bed Elevation
- to reduce ___ risk

A

aspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

General Supportive Care

Stress Ulcer Prophylaxis

stress related mucosal damage
* superficial lesions commonly involving the mucosal layer of the ___ following major stressful events
* clinically important bleeding likely uncommon (1.5%-5%), but associated with high morbidity and mortality (12.5%-20%)

risk factors
* shock, coagulopathy, chronic liver disease
* mechanical ___ /respiratory failure (?)
* others: neurotrauma, burn injury, extracorporeal life support
* drugs: antiplatelet agents, anticoagulants, ___

A
  • stomach
  • ventilation
  • NSAIDs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

General Supportive Care

Stress Ulcer Prophylaxis

prophylaxis (“SUP”)
* H2RAs
* PPIs
* ___ feeding - should not be used as sole prophylaxis in high-risk patients (add SUP)

PPIs vs H2RA is controversial
* guidelines do not recommend one vs the other
* some suggestion that PPIs may be more effective in preventing clinically important ___
* ___ SUP when risk factors no longer present

A
  • enteral
  • bleeding
  • d/c
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Stress Ulcer Prophylaxis

H2RAs (2)
* enteral or parenteral
* ADRs: potential ___ (rare)

A
  • thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Stress Ulcer Prophylaxis

PPIs (5)
- enteral or parenteral
- potential for risk ___ colitis, nosocomial pneumonia
- effect on mortality controversial

A
  • C. diff
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

SUP Summary

Prophylaxis generally considered to be warranted in critically ill patients
considered to be at high risk:
- mechanical ___
- chronic ___ disease
- shock
- coagulopathy

PPI vs H2RA controvercial
- PPIs have less ___ but more ___

d/c prophylaxis when risk factors no longer present

A
  • ventilation
  • liver
  • bleeding, infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

General Supportive Care

Glycemic Control

  • ___ is associated with increased ICU mortality

multifactorial causes (not limited to patients with underlying diabetes)
- underlying stress, TPN

in general target BG ___ - ___ mg/dl

initiate insulin if BG > ___ mg/dl
* sliding scale
* ___ infusion
* electronic glucose management systems
* avoid ___ insulin formulations in unstable patients

A
  • hyperglycemia
  • 144-180
  • 180
  • continuous
  • long-acting
22
Q

General Supportive Care

Spontaneous Awakening trial, Spontaneous Breathing Trial
- helps prevent ___ and promotes weaning from mechanical ___

A
  • oversedation
  • ventilation
23
Q

General Supportive Care

Bowel Regimen

hypomotility is common in critical illness
- particularly in patients on high dose/prolonged opioids

constipation
* stool softeners (e.g., ___ )
* laxatives ( ___, docusate sodium, lactulose)

gastroparesis
* promotility agents ( ___, ___)

D/C if patient is having diarrhea/frequent stools

A
  • senna
  • polyethylene glycol
  • metoclopramide, erythromycin
24
Q

General Supportive Care

Indwelling Catheters
- assess need, ___ regularly, remove if infected

De-escalation of Antibiotics
- often start with ___ coverage, refine and de-escalate based on culture results and clinical response

Delerium Assessment

A
  • replace
  • broad spectrum
25
Q

Neuromuscular Blocking Agents (NMBA’s, “paralytics”)

two types

A

depolarizing
nondepolarizing

26
Q

Succinylcholine

Physically resembles acetylcholine (Ach)
- activates Ach receptors
- sustained ___ of neuromuscular junction = muscle
contraction canʼt occur
- hydrolyzed much more ___ than Ach

  • May cause initial muscle ___
  • Dose: 1.5 mg/kg IV
  • Onset: ~1 minute
  • Duration ~3-5 minutes
  • Elimination: rapidly hydrolyzed in serum by the enzyme pseudocholinesterase
A
  • depolarization
  • slowly
  • contractions
27
Q

Succinylcholine

Used for ___ ___ ___ (RSI)
* placement of an endotracheal tube
* permits complete airway control and simplifies visualization of vocal cords

can cause initial muscle contractions
* may pre-administer defasciculating dose of ___ NMBA
immediately prior to succinylcholine

NOT used for ___ neuromuscular blockade

A
  • rapid sequence intubation
  • nondepolarizing
  • sustained
28
Q

Succinylcholine: ADRs

___ -> need to be ready to intubate

Muscle ___ -> deep aching muscle pain, may persist for days

Hyper ___ : precise mechanism unknown
- asynchronous ___ of muscle cells
- alterations in receptor sensitivity

contraindicated in major ___ , __ injury, and upper motor ___ disease
- potential life threatening ___
- unclear the precise duration that these contraindications should
persist

A
  • apnea
  • fasciculations
  • hyperkalemia
  • depolarization
  • burns, crush, neuron
  • hyperkalemia
29
Q

Succinylcholine: ADRs

Prolonged ___
* result of impaired ___ activity or decreased levels
* Intracranial pressure (ICP) ___ (controversial in TBI)
* Increased intraocular pressure (? clinically significant)

A

apnea
- pseudocholinesterase
- elevation

30
Q

Nondepolarizing NMBA’s

Competitively block the action of Ach (i.e., do NOT ___ receptors)
* do not cause initial ___
* competitive

2 general classes: ___ and ___

reversal possible, but generally not used in ICU
* acetylcholinesterase inhibitors ( ___ and ___)
* ___ - modified A-cyclodextrin for reversal of rocuonium/vecuronium

A
  • activate
  • fasciculations
  • aminosteroidal, benzylisoquinolinium
  • pyridostigmine, neostigmine
  • sugammadex
31
Q

Aminosteroidal NMBA’s

3 drugs

A
  • pancuronium
  • vecuronium
  • rocuronium
32
Q

Benzylisoquinolinium NMBA’s

2 drugs

A
  • atracurium
  • cisatracurium
33
Q

NDNMBA’s: Clinical Indications

May use for both ___ / ___ paralysis

Mechanical Ventilation
* generally in patients with acute lung injury or ___
* 25-50% of ARDS patients, recommended to administer as a ___ infusion

prevents ___ with ventilator, stops spontaneous respiratory effort
* improves gas exchange
* facilitates “nontraditional” methods of ventilation
* ___ required in all mechanically ventilated patients!

A
  • immediate/sustained
  • ARDS
  • continuous
  • NOT
34
Q

NDNMBA’s: Clinical Indications

Operative Settings
* muscle relaxation

RSI
* if contraindications to ___ (e.g., ___ , etc.)
* fast-acting agent

Manage Increased ___
* typically reserve for patients with severe posturing, difficulties in
mechanical ventilation, refractory increased ICP

Therapeutic ___
* body temp 32-34 C post cardiac arrest
* prevent/treat ___

___ Oxygen Consumption
* controversial -> severe ___ may be associated with high oxygen demands,
may improve “supply-demand” relationship

A
  • succinylcholine, burns
  • ICP
  • hypothermia
  • shivering
  • decrease
35
Q

NDNMBA’s: ADR’s

Paralysis of ___ muscles/ ___
* safeguards to prevent unplanned extubation

Inadequate ___ and ___
* NMBAʼs do NOT provide analgesic, sedative, or anxiolytic effect
* patients still feel pain and anxiety, however are unable to communicate
* no longer able to assess typical symptoms of pain and anxiety
* patients must be optimized on ___ and ___ drugs (ideally ___ to initiation of NMBA)

A
  • respiratory, apnea
  • pain, sedation
  • sedative, analgesic, prior
36
Q

NDNMBA’s: ADR’s

Prolonged Paralysis/Muscle Weakness
- ICU-acquired skeletal muscle weakness (ICUAW)
- acute quadriplegic myopathy syndrome (AQMS)
- critical illness myopathy (CIM)
- critical illness polyneuropathy (CIP)

multifactorial:
* pharmacokinetic effected ( ___ ) possible pharmacodynamic effects
* risk increased with ___ NMBA administration, possibly
increased with ___ , ___ , or ___ shock
* drug holidays may decrease the incidence of AQMS

all those are the same thing

A
  • accumuation
  • polonged
  • corticosteroids, sepsis, septic

corticosteroid thing controversial

37
Q

NDNMBA’s: ADR’s

Msc ADRʼs
related to immobility
* ___ prophylaxis
* ocular ___

agent specific ADRʼs
* Drug Interactions - ___ and NMBAʼs (note that contribution is controversial)

A
  • DVT
  • lubricants
  • corticosteroids
38
Q

Monitoring Sustained NMB

Challenging (and often misunderstood)
* Associated with significant ___ in response
* Goal: ___ dose possible, minimization of ADRʼs
* efficacy endpoint -> based on clinical indication
* difficult to assess

A
  • variability
  • lowest
39
Q

Monitoring Sustained NMB

___ endpoint -> Peripheral nerve stimulation (“twitch monitoring”, train-of-four [TOF] assessment):
- nerve stimulated 4 times
- 4/4 = < 75% suppression
- 3/4 = 75% suppression
- 2/4 = 80% suppression
- 1/4 = 90% suppression
- 0/4 = 100% suppression

titrating to ___ should be avoided
- adjust dose to 1-2 twitches of train

A
  • toxicity
  • 0/4
40
Q

PADIS

A

pain, agitation/sedation, delirium, immobility, sleep

41
Q

Pain and Analgesia

poorly treated in hospitalized patients
- most (≥50%) ICU patients experience pain
- many unable to self report

pain related stress response
* increases ___ nervous system activation, raises ___ levels
* vaso ___ , impaired tissue perfusion
* catabolism/ ___
* impaired wound healing/increased wound infection
* ___ suppression
* can alter ___ patterns and mechanics

A
  • sympathetic, catecholamine
  • vasoconstriction
  • hypermetabolism
  • immunosuppression
  • breathing
42
Q

Pain Assessment

if unable to self report
* ___ : facial expression, upper limb movements, compliance with
mechanical ventilation (each rated on scale of 1-4, total score 3-12)
* ___ : facial expression; body movements; muscle tension; compliance with mechanical ventilation OR vocalization (each rated on scale of 0-2, total score 0-8

A
  • BPS: Behavioral Pain Scale
  • CPOT: Critical Care Pain Obseravtion Tool
43
Q

in general, IV ___ preferred for non-neuropathic pain in critically ill
patients
- equally effective when titrated to similar endpoints
- note that opioids may have ___ effects

non-opioid analgesics may be used to ___ opioid requirements (mulit-
modal approach)
- acetaminophen
- ___ pain medications (gabapentin, pregabalin, carbamazepine)
- NSAIDs (don’t routinely use)
- ketamine (post surgery)

A
  • opioids
  • sedative
  • decrease
  • neuropathic
44
Q

Agitation/Sedation

agitation = state of anxiety accompanied by motor restlessness

frequent in critically ill patients, associated with adverse clinical outcomes
* ventilator ___
* inappropriate verbal behavior
* physical ___
* increased motor activity
* increases in oxygen consumption
* inadvertent removal of devices and indwelling lines and catheters

A
  • dysynchrony
  • aggression
45
Q

Agitation/Sedation

underlying causes of agitation

A
  • pain
  • mechanical ventilation
  • delirium
  • hypoxia
  • hypotension
  • withdrawal (EtOH, drugs)
46
Q

Treatment of Agitation

nonpharmacologic efforts
* maintenance of patient comfort
* provision of adequate ___
* frequent reorientation
* optimization of environment to maintain normal ___ pattern
* many (this used to say most) patients requiring mechanical ___ will
require some pharmacological ___

A
  • analgesia
  • sleep
  • ventilation
  • sedation
47
Q

Treatment of Agitation-Sedation

pharmacologic sedation should be started after providing adequate ___ and treating reversible physiological causes

should not be used as a method of restraint, coercion, discipline, convenience,
or retaliation

A

analgesia

48
Q

Treatment of Agitation-Sedation

degree of sedation in part depends on patient’s need/ability to protect ___
* over sedation is problematic
* increase time on mechanical ___
* ___ ICU and hospital length of stay
* obscure neurological function testing

A

airway
- ventilation
- increase

49
Q

Treatment of Agitation-Sedation

Goal: adequate sedation, but not over sedation
* LESS IS BEST
* calm ___ patient, able to purposefully follow simple commands

Benefits
- decreased duration of mechanical ventilation
- decrease in ICU LOS
- possible decrease in mortality (controversial)

efforts to achieve light sedation should be empoyed
- daily sedation ___
- nursing-protocolized target sedation

A
  • arousable
  • interruption
50
Q

Assessment of Sedation

assessment facilitates titration of sedatives to pre-determined endpoints
- subjective assessment is difficult in patients with altered level of mentation or inability to outwardly express anxiety

2 sedation scales: ___ and ___

A
  • Richmond-Agitation-Sedation Scale (RASS)
  • Sedation-Agitation Scale (SAS)
51
Q

Assessment of Sedation

____ ___ ___ Scale ( ___ ):
* 10-point scale
* four levels of anxiety or agitation (1 to 4)
* one level to denote a calm and alert state (0)
* 5 levels of sedation (-1 to -5)

___ :
* consciousness and agitation from a 7-item list
* 1=unarousable
* 7=dangerously agitated

A
  • Richmond Sedation Agitation Scale (RASS)
  • SAS
52
Q

Assessment of Sedation

objective assessment
___ ___ ( ___ ):
* digital scale from 100 (completely awake) to 0 (isoelectric EEG)

guidelines suggest using in patients in whom other measures are not feasible (e.g., deep sedation, neuromuscular blockade)
- currently do not recommend BIS monitoring (or other objective measures of brain function) in all sedated ICU patients
- recommend EEG monitoring for non-convulsive seizure activity in ICU patients with known/suspected seizures or to titrate medications to achieve burst suppression

A
  • Bispectral Index (BIS)